Quarterly report pursuant to Section 13 or 15(d)

Supplemental Cash Flow Information

v3.2.0.727
Supplemental Cash Flow Information
 6 Months Ended
Jun. 30, 2015
Notes  
Supplemental Cash Flow Information

11.  SUPPLEMENTAL CASH FLOW INFORMATION

 

 

Six months ended June 30,

 

2015

 

2014

Cash paid for interest

$

25,356

 

$

152,813

Series C Dividend payable in accrued expenses

$

--

 

$

17,870

Series D Dividend payable in accrued expenses

$

26,555

 

$

49,237

 

 

 

 

 

 

Non-Cash investing and financing transactions

 

 

 

 

 

Shares issued for consulting services

$

25,500

 

$

--

Beneficial conversion feature on warrants issued in conjunction with Series D preferred shares

$

--

 

$

24,279

Shares issued in acquisition of Dr. Pave

$

--

 

$

175,000